A care program after hospital discharge for people with severe asthma attacks in India
Tests an asthma care program after hospital stays for severe asthma attacks.
Plain-language title generated from the registry record
Registry title: Development and Validation of the Indian Asthma Care Bundle for Reducing Readmission and Improving Post-hospitalisation Care After Discharge From Hospital Due to an Acute Asthma Exacerbation
Key facts
- Where
- Delhi and Kolkata, IndiaSee the 2 sites
Where in India
- Vardhman Mahavir Medical College and Safdarjung HospitalDelhi, IndiaNo longer taking part
- Apollo Multispeciality Hospitals (previously Apollo Gleneagles Hospital)Kolkata, IndiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ahmedabad University
- Trial code
- NCT07815730
- Record updated
- 11 September 2026
- Original description
The goal of this study is to assess the effectiveness of the Indian Asthma Care Bundle (I-ACB) in improving post-discharge asthma management among patients with asthma in India, specifically targeting adults and children experiencing severe asthma exacerbations.Read full original descriptionShow less
Development, Validation, Reliability, and Effectiveness of an Indian Asthma Care Bundle (I-ACB): a Prospective Multicentre Cohort Study
The goal of this study is to assess the effectiveness of the Indian Asthma Care Bundle (I-ACB) in improving post-discharge asthma management among patients with asthma in India, specifically targeting adults and children experiencing severe asthma exacerbations.
The main questions it aims to answer are:
1. Does the I-ACB reduce the rate of hospital readmissions within 30, 60, and 90 days post-discharge? 2. How does the I-ACB impact treatment adherence, lung function, symptom control, and overall quality of life, compared to usual care?
Researchers will compare outcomes among participants receiving the I-ACB with those receiving standard asthma care (usual care) to determine whether the I-ACB improves health outcomes and reduces the need for emergency department visits.
Participants will be asked to:
* Engage in a structured asthma management program that includes education on inhaler techniques and adherence to treatment plans. * Report their symptoms and treatment adherence regularly. * Participate in follow-up assessments that monitor lung function and quality of life over a specified period.
The importance of this study lies in its potential to address significant gaps in asthma management in India, which currently lead to high hospitalisation rates and substantial healthcare costs. By developing a tailored care strategy, the I-ACB aims to improve health outcomes for millions of asthma patients, reducing the burden on families and healthcare systems alike, and ultimately transforming the approach to asthma care in the region.
Inclusion: Adults (≥ 18 years of age) participants with a doctor-diagnosed asthma; admitted to a tertiary care facility/hospital due to an acute asthma exacerbation; attended at least a primary school to read, comprehend, and write English/Hindi/local language; provide informed consent.
Exclusion: a diagnosed co-pulmonary condition, such as chronic obstructive pulmonary disease, bronchiectasis, interstitial lung disease or other chronic respiratory disorders; a recent (in the past 6 months) history of hospitalisation due to influenza, pneumonia, or any respiratory tract infections; a recent (in the past 6 months) hospital admission due to a cardiologic condition or under medications such as statins, beta-blockers, blood thinners, etc; a significant cognitive impairment; very low educational attainment (≤ primary school education); transferred to another healthcare facility before discharge; discharged against medical advice.